Sign in

CIK 0001980845 · <br>Emerging growth company

enGene Therapeutics Inc.

Sign in to watch
Ticker
ENGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Oct 31
Incorporated
Canada (Federal Level)
Entity type
operating
Phone
(514) 332-4888
Business address
4868 RUE LEVY, SUITE 220, SAINT-LAURENT, Quebec, Canada
Former names
enGene Holdings Inc.

Securities

  • ENGN Common Stock Nasdaq
  • ENGNW Warrants Nasdaq
  1. 8-K Event Executive or director change
  2. 8-K/A Event Executive or director change
  3. 8-K Event Regulation FD disclosure
  4. 8-K Event Results of operations
  5. 8-K Event Regulation FD disclosure · Other events
  6. 8-K Event Executive or director change · Regulation FD disclosure
  7. 8-K Event Results of operations
  8. 8-K Event Executive or director change · Shareholder vote results
  9. 8-K Event Material agreement · New debt or obligation
  10. 8-K Event Executive or director change · Regulation FD disclosure
  11. DEF 14A Proxy Proxy Statement
  12. 8-K Event Results of operations
  13. 10-K/A Report 10-K/A
  14. 8-K Event Material agreement
  15. 10-K Report Annual Report
  16. 8-K Event Material agreement · Results of operations · New debt or obligation
  17. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
  18. 8-K Event Executive or director change · Regulation FD disclosure · Other events
  19. 8-K Event Regulation FD disclosure · Other events
  20. 8-K Event Results of operations

Page 2 of 3 · 55 filings